Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carliprazine vs Aripiprazole in Acute Schizophrenia
NCT06589817Phase 3Not yet recruiting
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Oct 2024
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06589817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06589817.